Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-020412·Bain Capital Life Sciences Opportunities III, LP
Schedule 13G ownership disclosure
Disc Medicine Inc
Common Stock, $0.0001 par value per share · CUSIP: 254604101
Event date: 2024-12-31
- Filing-level shares
- 983,500
- Percent of class
- 3.3%
- Bain Capital Life Sciences Opportunities III, LP
Shares: 983,500 · Class: 3.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020412
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Opportunities III, LP
- CIK
- CIK 1950105
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership